News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2023 Shelley Wood November 30, 2023
News Daily News Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO Todd Neale November 29, 2023
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Conference News TCT 2023 VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli L.A. McKeown October 27, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
Presentation TCT 2023 Four-Year Outcomes From the EVOLUT Low Risk Trial Presenter: Michael Reardon October 24, 2023
News Daily News SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry Yael L. Maxwell October 20, 2023
News Conference News EACTS 2023 AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair Michael O'Riordan October 09, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Daily News High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD Todd Neale August 01, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Conference News EuroPCR 2023 Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics Michael O'Riordan May 17, 2023
News Daily News Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data Michael O'Riordan March 29, 2023
Presentation ACC 2023 Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial Presenter: John K. Forrest March 05, 2023
News Conference News ACC 2023 Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients Todd Neale March 05, 2023